Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression
| Image |  |
|---|---|
| Description | scientific article published on 11 May 2011 |
| Author/s |
author: Masafumi Taniwaki |
| Publication date | May 11, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |